Paradise Genomics

Paradise Genomics is a private U.S. biotechnology company focused on discovering disease-specific gene expression signatures from whole blood and tissue samples for diagnostic, prognostic, and therapeutic-monitoring applications. The company markets a platform for identifying highly discriminative genomic "bioprofiles" that can be translated into clinical assays or partnered with strategic diagnostics companies. Publicly available information indicates work spanning oncology, gastrointestinal disease, neuropsychiatric disorders, and pain-related conditions, with examples including gastric cancer, celiac disease, major depressive disorder, bipolar disorder, and fibromyalgia. Paradise Genomics appears to operate primarily as a platform and biomarker-discovery company rather than a therapeutics developer, and it has sought commercialization partners to bring its signatures into clinical diagnostic products.